CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
In a small group of patients with hereditary ATTR amyloidosis with polyneuropathy, administration of NTLA-2001 was associated with only mild adverse events and led to decreases ...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,432
- Institution
- Clinical Trials New Zealand
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.